Label: OPHTHAVET- hyaluronate sodium ointment
- NDC Code(s): 17033-047-05
- Packager: Dechra Veterinary Products
- Category: OTC ANIMAL DRUG LABEL
- DEA Schedule: None
- Marketing Status: unapproved drug other
DISCLAIMER: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.
Drug Label Information
Updated September 14, 2021
If you are a consumer or patient please visit this version.
- Download DRUG LABEL INFO: PDF XML
- Official Label (Printer Friendly)
- SPL UNCLASSIFIED SECTION
- SAFE HANDLING WARNING
- STORAGE AND HANDLING
- DESCRIPTION
- VETERINARY INDICATIONS
- DOSAGE & ADMINISTRATION
- SPL UNCLASSIFIED SECTION
- PRINCIPAL DISPLAY PANEL - 5 g Tube Carton
-
INGREDIENTS AND APPEARANCE
OPHTHAVET
hyaluronate sodium ointmentProduct Information Product Type OTC ANIMAL DRUG Item Code (Source) NDC:17033-047 Route of Administration OPHTHALMIC Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength HYALURONATE SODIUM (UNII: YSE9PPT4TH) (HYALURONIC ACID - UNII:S270N0TRQY) HYALURONATE SODIUM 4 mg in 1 g Inactive Ingredients Ingredient Name Strength MINERAL OIL (UNII: T5L8T28FGP) PETROLATUM (UNII: 4T6H12BN9U) WATER (UNII: 059QF0KO0R) LANOLIN ALCOHOLS (UNII: 884C3FA9HE) POTASSIUM SORBATE (UNII: 1VPU26JZZ4) MONOBASIC POTASSIUM PHOSPHATE (UNII: 4J9FJ0HL51) SODIUM HYDROXYMETHYLGLYCINATE (UNII: DIG6BWZ9XT) SODIUM PHOSPHATE, DIBASIC, ANHYDROUS (UNII: 22ADO53M6F) SODIUM CHLORIDE (UNII: 451W47IQ8X) Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:17033-047-05 5 g in 1 TUBE Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date Unapproved drug other 07/15/2021 Labeler - Dechra Veterinary Products (362142734)